1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Clinical outcomes

OutcomeProcedure No. (%)
Periprocedural outcomes (within 30 days)
 Major adverse eventsa
  Death from subdural hemorrhage1 (2.3)
  Cranial nerve palsyb1 (2.3)
 Minor adverse events
  Stroke/TIA1 (2.3)
  Headacheb1 (2.3)
Postprocedure outcomes (30 days to 1 yr)
 Major adverse eventsa
  Pulsatile tinnitus (carotid cavernous fistula)1 (2.3)
  Mass effect causing reduced visual acuity1 (2.3)
  • a An ongoing clinical event at 7 days following the event.

  • b Same patient.